Presence of lipids in urine, crystals and stones: Implications for the formation of kidney stones

Kidney International

Volumn 62, Issue 6, 2002, Pages 2062-2072

  Khan, Saeed R ^a   Glenton, Patricia A ^a   Backov, Renal ^a   Talham, Daniel R ^a  

^a University of Florida ^*  (United States)

Author keywords

Calcium oxalate; Cell membrane; Nephrolithiasis; Phosphatidylserine; Phospholipids

Indexed keywords

1 PALMITOYL 2 OLEOYLGLYCERO 3 PHOSPHOGLYCEROL; 1,2 DIPALMITOYLPHOSPHATIDYLGLYCEROL; 1,2-DIPALMITOYLPHOSPHATIDYLGLYCEROL; 1-PALMITOYL-2-OLEOYLGLYCERO-3-PHOSPHOGLYCEROL; CALCIUM OXALATE; DIMYRISTOYLPHOSPHATIDYLGLYCEROL; DIOLEOYLPHOSPHATIDYLTHIOGLYCEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLSERINE; LIPID; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLSERINE; CALCIUM ION; CALCIUM PHOSPHATE; CHOLESTEROL; CHOLESTEROL ESTER; DIOLEOYLPHOSPHATIDYLGLYCEROL; DIPALMITOYLPHOSPHATIDYLGLYCEROL; MEMBRANE PHOSPHOLIPID; PALMITOYLOLEOYLPHOSPHATIDYLGLYCEROL; PHOSPHOLIPID DERIVATIVE; STRUVITE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID;

ADULT; AGED; ARTICLE; CHEMISTRY; CRYSTALLIZATION; FEMALE; HUMAN; MALE; MEMBRANE FLUIDITY; MIDDLE AGED; NEPHROLITHIASIS; URINE; CATALYSIS; CONTROLLED STUDY; KIDNEY EPITHELIUM; PRECIPITATION; PRIORITY JOURNAL; URINALYSIS;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ADULT; AGED; AGED, 80 AND OVER; CALCIUM OXALATE; CRYSTALLIZATION; FEMALE; HUMANS; KIDNEY CALCULI; LIPIDS; MALE; MEMBRANE FLUIDITY; MIDDLE AGED; PHOSPHATIDYLGLYCEROLS; PHOSPHATIDYLSERINES;

EID: 0036434901     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00676.x     Document Type: Article

References (50)

1. Wuthier RE: Lipids of mineralizing epiphyseal tissues in the bovine fetus. J Lipid Res 9:68-79, 1968
2. Boskey AL: Current concepts of physiology and biochemistry of calcification. Clin Orthop 157:225-257, 1981
3. Anderson HC: Calcific diseases. Arch Pathol Lab Med 107:341-348, 1983
4. Slomiany BL, Murty VLN, Aono M, et al: Lipid composition of the matrix of human submandibular salivary gland stones. Arch Oral Biol 27:673-677, 1982
5. Boskey AL, Burstein LS, Mandel ID: Phospholipids associated with human parotid gland sialoliths. Arch Oral Biol 28:655-657, 1983
6. Boskey AL, Boyan-Salyers BD, Burnstein LS, Mandel ID: Lipids associated with mineralization of human submandibular gland sialoliths. Arch Oral Biol 26:779-785, 1981
7. Khan SR, Shevock PN, Hackett RL: Presence of lipids in urinary stones: Results of preliminary studies. Calcif Tissue Int 42:91-96, 1988
8. Khan SR, Shevock PN, Hackett RL: In vitro precipitation of calcium oxalate in the presence of whole matrix or lipid components of the urinary stones. J Urol 139:418-422, 1988
9. Khan SR, Hackett RL: Calcium oxalate urolithiasis in the rat: Is it a model for human stone disease? A review of recent literature. Scanning Microsc 2:759-774, 1985
10. Khan SR: Animal models of kidney stone formation: An analysis. World J Urol 15:236-243, 1997
11. Khan SR, Whalen PO, Glenton PA: Heterogeneous nucleation of calcium oxalate crystals in the presence of membrane vesicles. J Crystal Growth 134:211-218, 1993
12. Fasano JM, Khan SR: Intratubular crystallization of calcium oxalate in the presence of membrane vesicles: An in vitro study. Kidney Int 59:169-178, 2001
13. Boskey AL: Role of calcium-phospholipid-phosphate complexes in tissue mineralization. Met Bone Dis Relat Res 1:137-142, 1978
14. Boyan BD, Boskey AL: Co-isolation of proteolipids and calcium-phospholipid-phosphate complxes. Calcif Tissue Res 36:214-218, 1984
15. Boskey AL, Ullrich W, Spevak L, Gilder H: Persistence of complexed acidic phospholipids in rapidly mineralizing tissues is due to affinity for mineral and resistance to hydrolytic attack: In vitro data. Calcif Tissue Int 58:45-51, 1996
16. Mann S, Heywood BR, Rajam S, Birchall JD: Controlled crystallization of calcium carbonate under stearic acid monolayers. Nature 334:692-694, 1988
17. Atmani F, Glenton PA, Khan SR: Identification of proteins isolated from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects. Urol Res 26:201-207, 1998
18. Khan SR, Glenton PA: Increased urinary excretion of lipids by patients with kidney stones. Br J Urol 77:506-511, 1996
19. Whipps S, Khan SR, Opalko FJ, et al: Growth of calcium oxalate monohydrate at phospholipid Langmuir monolayers. J Crystallogr Growth 192:243-249, 1998
20. Backov R, Khan SR, Mingotaud C, et al: Precipitation of calcium oxalate monohydrate at phospholipid monolayers. J Am Soc Nephrol 10(Suppl):S359-S363, 1999
21. Backov R, Lee CM, Khan SR, et al: Calcium oxalate monohydrate precipitation at phosphatidylglycerol langmuir monolayers. Langmuir 16:6013-6019, 2000
22. Werness P, Brown C, Smith L, Finlayson B: EQUIL 2: Basic computer program for the calculation of urinary saturation. J Urol 134:1242-1244, 1985
23. Martin RS, Small DM: Physicochemical characterization of the urinary lipid from humans with nephrotic syndrome. J Lab Clin Med 103:798-810, 1984
24. Uyama E, Kutsukake Y, HARA A, et al: Abnormal excretion of urinary phospholipids and sulfatides in patients with mitochondrial encephalomyopathies. Biochem Biophys Res Comm 194:266-273, 1993
25. Josepovitz C, Levine R, LANE B, Kaloyanides J: Contrasting effects of gentamicin and mercuric chloride on urinary excretion of enzymes and phospholipids in the rat. Lab Invest 52:375-386, 1985
26. Lieske JC, Hammes MS, Hoyer JR, Toback FG: Renal cell osteopontin production is stimulated by CaOx monohydrate crystals. Kidney Int 51:679-686, 1997
27. Gokhale JA, Glenton PA, Khan SR: Immunocytochemical Tamm-Horsfall. Nephron 73:456-461, 1996
28. Iida S, Peck AB, Johnson-Tardieu J, et al: Temporal changes in mRNA expression for bikunin in the kidneys of rats during CaOx nephrolithiasis. J Am Soc Nephrol 10:986-996, 1999
29. Iida S, Peck AB, Byer KJ, Khan SR: Expression of bikunin mRNA in renal epithelial cells after oxalate exposure. J Urol 162:1480-1486, 1999
30. Gokhale JA, Glenton PA, Khan SR: Chracterization of Tamm-Horsfall protein in a rat nephrolithiasis model. J Urol 166:1492-1497, 2001
31. Zager RA, Burkhart KM, Johnson ACM, Sacks BM: Increased proximal tubular cholesterol content: Implications for cell injury and acquired cytoresistance. Kidney Int 56:1788-1797, 1999
32. Boskey AL: Phospholipids and calcification, in Calcified Tissue, edited by Hukins DWL, Boca Raton, CRC Press, 1989, pp 215-243
33. Schoen FJ, Harasaki H, Kim KM, et al: Biomaterial-assisted calcification: Pathology, mechanisms, and strategies for prevention. J Biomed Mater Res 22:11-36, 1988
34. Khan SR: Wilkinson EJ: Scanning electron microscopy, x-ray diffraction, and electron microsprobe analysis of calcific deposits on intrauterine contraceptive devices. Hum Pathol 16:732-738, 1985
35. Khan SR: Heterogeneous nucleation of calcium oxalate crystals in mammalian urine. Scanning Microsc 9:597-616, 1995
36. Molitoris BA, Simon FR: Renal cortical brush-border and basolateral membranes: Cholesterol and phospholipid composition and relative turnover. J Membr Biol 83:207-215, 1985
37. Letellier SR, Lochhead MJ, Cambell AA, Vogel V: Oriented growth of calcium oxalate monohydrate crystals beneath phospholipid monolayers. Biochim Biophys Acta 1380:31-45, 1998
38. Mandel NS: Crystal-membrane interaction in kidney stone disease. J Am Soc Nephrol 5(Suppl):S37-S45, 1994
39. Lieskae JC, Toback FG, Deganello S: Face-selective adhesion of calcium oxalate dihydrate crystals to renal epithelial cells. Calcif Tissue Intl 58:195-200, 1996
40. Lieske JC, Toback FG, Deganello S: Direct nucleation of calcium oxalate dihydrate crystals onto the surface of living epithelial cells in culture. Kidney Intl 54:796-803, 1998
41. Lieske JC, Huang E, Toback FG: Regulation of renal epithelial cell affinity for calcium oxalate monohydrate crystals. Am J Physiol 278:F130-F137, 2000
42. Trump BF, Berezeski IK: Calcium-mediated cell injury and cell death. FASEB J 9:219-228, 1995
43. Khan SR, Byer KJ, Thamilselvan S, et al: Crystal-cell interaction and apoptosis in oxalate-associated injury of renal epithelial cells. J Am Soc Nephrol 10(Suppl):S457-S463, 1999
44. Koul H, Kenington L, Nair G, et al: Ox-induced initiation of DNA synthesis in LLC-PK1 cells, a line of renal epithelial cells. Biochem Biophys Res Comm 205:1632-1637, 1994
45. Wiessner JH, Hasegawa AT, Hung LY, Mandel NS: Oxalate-induced exposure of PS on surface of renal epithelial cells in culture. J Am Soc Nephrol 10(Suppl):S441-S445, 1999
46. Jonassen JA, Cooney R, Kennington L, et al: Ox-induced changes in the viability and growth of human renal epithelial cells. J Am Soc Nephrol 10(Suppl):S446-S451, 1999
47. Koul HK, Koul S, Fu S, et al: Oxalate: From crystal formation to crystal retention. J Am Soc Nephrol 10:S417-421, 1999
48. Cao L-C, Jonassen J, Honeyman TW, Scheid C: Oxalate-induced redistribution of phosphatidylserine in renal epithelial cells, implication for kidney stone disease. Am J Nephrol 21:69-77, 2001
49. Wiessner JH, Hasegawa AT, Hung LY, et al: Mechanisms of calcium oxalate crystal attachment to injured renal collecting duct cells. Kidney Int 59:637-644, 2001
50. Khan SR: Interactions between stone forming calcific crystals and macromolecules. Urol Int 59:59-71, 1997